The CAIRO and FOCUS Studies: Which Lesson Is to Be Learned?
Author:
Affiliation:
1. a Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
2. b St James’s Institute of Oncology, University of Leeds, United Kingdom
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2008-0247
Reference5 articles.
1. Innovations in chemotherapy for metastatic colorectal cancer: An update of recent clinical trials;O’Neil;The Oncologist,2008
2. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): A phase III randomised controlled trial;Koopman;Lancet,2007
3. Different strategies of sequential and combination chemotherapy for patients with poor-prognosis advanced colorectal cancer (MRC FOCUS): A randomised controlled trial;Seymour;Lancet,2007
4. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004
5. New options and old dilemmas in the treatment of patients with advanced colorectal cancer;Punt;Ann Oncol,2004
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019;Expert Review of Anticancer Therapy;2020-04-02
2. KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2019-12
3. Targeted therapy for metastatic colorectal cancer;Expert Review of Anticancer Therapy;2018-08-03
4. CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES;Medical Council;2017-11-14
5. Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015;Expert Review of Anticancer Therapy;2016-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3